Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price increase of 25.00%. However, over the past six months, we’ve seen a weaker performance of 45.30%. The price of ARTL leaped by -7.52% over the last 30 days. And in the last five days, it has fallen by -25.71%.
The stock price for Artelo Biosciences Inc (ARTL) currently stands at $10.2. The stock experienced a substantial increase in the last session, hitting $20.0 after starting at $10.2. The stock’s lowest price was $20.0 before closing at $11.86.
Artelo Biosciences Inc’s market performance has been stable in recent times.
52-week price history of ARTL Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Artelo Biosciences Inc’s current trading price is -64.34% away from its 52-week high, while its distance from the 52-week low is 107.42%. The stock’s price range during this time has been between $4.92 and $28.60. The trading volume for the Healthcare sector company’s shares reached about 0.61 million for the day, which was lower than the average daily volume of 0.63 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Artelo Biosciences Inc (ARTL) has experienced a quarterly rise of 68.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.19M and boasts a workforce of 6 employees.
Artelo Biosciences Inc: Analysts’ Ratings Unveiled
As of right now, 1 analyst is rating Artelo Biosciences Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.15, with a change in price of +4.26. Similarly, Artelo Biosciences Inc recorded 445,984 in trading volume during the last 100 days, posting a change of +71.72%.
ARTL’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ARTL stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.09.
ARTL Stock Stochastic Average
Today, Artelo Biosciences Inc’s raw stochastic average for the past 50 days stands at 19.96%, indicating a rise from the raw stochastic average of the last 20 days, which was 1.97%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 8.80% and 13.51% respectively.
